Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tigecycline fumarate with transversus abdominis plane block for multimodal analgesia after laparoscopic gastrointestinal tumor surgery
ChiCTR2500112722Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of University of Science and Technology of China
- Start
- Nov 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tigecycline in gastrointestinal cancer (4 arms), sponsored by The First Affiliated Hospital of University of Science and Technology of China. Primary endpoint: Difference in resting/motor pain intensity within 24 hours after surgery. Started Nov 2025; status: recruiting.
02
Drugs
tigecycline
03
Conditions
gastrointestinal cancer
Beyond the preview
Go deeper on ChiCTR2500112722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500112722.